BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer...

July 01, 2026 | News

CanSinoBIO Secures Argentina Approval for Menhycia Quadrivalent Meningococcal Conjugate Vaccine

CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) (the "MCV4",...

July 01, 2026 | News

DoH Abu Dhabi and Sanofi Deepen Partnership to Build Next-Generation Vaccine Innovation Hub

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines...

June 24, 2026 | News

SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with t...

June 11, 2026 | News

SK Bioscience Secures First UNICEF Influenza Vaccine Contract Across Both Hemispheres

First UNICEF procurement contract strengthens SK bioscience's presence in global public procurement markets Dual-hemisphere supply programs enhance manu...

June 04, 2026 | News

SK bioscience Partners With Colombia On US$260 Million Vaccine Localization Initiative

SK bioscience collaborates with Colombia's government-led US$260 million vaccine localization initiative through technology transfer and local manufactur...

May 28, 2026 | News

WuXi Vaccines Secures Second ANVISA GMP Certification To Accelerate Brazil Dengue Vaccine Manufacturing

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...

May 27, 2026 | News

VectorBuilder Secures European Patent For MiniVec Plasmid System Advancing Genetic Medicine Development

Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines VectorBuilder, a global leader in ...

May 06, 2026 | News

Everest Medicines Reports Promising First In Human Data For Personalised mRNA Cancer Vaccine EVM16

Everest Medicines announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized mRNA cancer vaccine, were presen...

April 24, 2026 | News

Delonix Bioworks Initiates First In Human Trial Of DX 104 For Meningococcal B Vaccine

Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced the initiation of first-in-h...

April 01, 2026 | News

Centivax Secures 37 Million Dollars In Oversubscribed Financing To Advance Universal Influenza Vaccine

Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets,...

April 01, 2026 | News

GC Biopharma Secures First Latin America Approval For Antibiotic Free Varicella Vaccine

First regulatory clearance in Latin America marks a strategic milestone for regional market expansion- World's first antibiotic-free manufacturing process ...

March 27, 2026 | News

Naobios And SGS Partner To Manufacture RSV Challenge Agent For Human Infection Studies

Collaboration supports Controlled Human Infection Model (CHIM) studies that help accelerate development of effective and affordable RSV vaccines ...

March 10, 2026 | News

Sino Biological Launches 2026 To 2027 Influenza Vaccine Strain Antigens Following WHO Recommendations

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighti...

March 06, 2026 | News

Stay Connected